Ingrid Goldberg | Vice President of Investor Relations |
William Doyle | Executive Chairman |
Asaf Danziger | Chief Executive Officer |
Ashley Cordova | Chief Financial Officer |
Frank Leonard | President, CNS Cancers U.S. |
Greg Fraser | Truist Securities |
Emily Bodnar | H.C. Wainwright |
Na Sun | JPMorgan Chase & Co. |
Good day, and thank you for standing by. Welcome to the NovoCure's Q1 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead.